ClinicalTrials.gov
public full text
Public Domain
Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response
The purpose of this study is to determine which B lymphocytes subsets are responsible for the production of IgM, IgG2 and IgA anti-pneumococcal capsular polysaccharides after vaccination with a 23-valent pneumococcal polysaccharide vaccine.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines#387200
- An overview of the clinical development of the 20-valent pneumococcal conjugate vaccine in adults#4644
- Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine#230442
- Immunological Memory Against Pneumococcus Induced by 3 Infant PCV 13 Vaccination Schedules#1096728
- Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine#143648
Record · ID 910540
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive